FAKTOR-OPTIONSSCHEIN - BRISTOL-MYERS SQUIBB | Market Closed - Börse Stuttgart 15:21:29 2024-06-21 EDT | ||
| 17.25 EUR | -5.48% |
|
| Current month | -6.20% | ||
| 1 month | +3.67% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-06-21 | 17.25 | -5.48% |
| 24-06-20 | 18.25 | +0.33% |
| 24-06-19 | 18.19 | -1.41% |
| 24-06-18 | 18.45 | +1.37% |
| 24-06-17 | 18.2 | +3.00% |
Delayed Quote Börse Stuttgart
Last update June 21, 2024 at 03:21 pm
More quotesStatic data
| Product type | Warrant Esotici e Strutturati |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | Morgan Stanley |
| WKN | MG0M77 |
| ISIN | DE000MG0M772 |
| Date issued | 2024-03-21 |
| Strike | 54.72 $ |
| Maturity | Unlimited |
| Parity | 0.7 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 19.34 € |
|---|---|
| Lowest since issue | 8.86 € |
| Spread | 0.02 € |
| Spread % | 0.12% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.93
USD
Average target price
53.19
USD
Spread / Average Target
+26.87%
- Stock Market
- Certificates
- Certificat
